Search for " " - Xconomy

Results for “ ”

Entry	Author	Date	Location
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers	Frank Vinluan	01/17/20	San Francisco
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More	Frank Vinluan	01/17/20	National
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data	Frank Vinluan	01/14/20	National
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans	Frank Vinluan	01/13/20	Boston
Roche Pays $40M to Use Amunix Pharma’s Half-Life Extension Tech	Melissa Fassbender	01/13/20	National
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial	Sarah de Crescenzo	01/13/20	San Francisco
Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira	Frank Vinluan	01/10/20	Indiana
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More	Sarah de Crescenzo	01/10/20	National
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy	Frank Vinluan	01/08/20	San Francisco
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic	Frank Vinluan	01/07/20	Boston
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More	Frank Vinluan	01/03/20	National
After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger	Sarah de Crescenzo	01/03/20	San Diego
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More	Sarah de Crescenzo	12/20/19	National
Triplet Therapeutics Unveils $59M to Try Hairpin Fix for Huntington’s	Frank Vinluan	12/17/19	Boston
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More	Frank Vinluan	12/13/19	National
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning	Frank Vinluan	12/12/19	National
Iterum’s Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink	Frank Vinluan	12/11/19	National
BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs	Melissa Fassbender	12/09/19	San Francisco
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More	Sarah de Crescenzo	12/06/19	National
Digital Health Survivors & Innovative Incumbents Must Team Up for True Disruption	Bryony Winn	12/04/19	Raleigh Durham
Roche Notches FDA Nod in Lung Cancer, Amps Up Competition With Merck	Frank Vinluan	12/04/19	San Francisco
Stemonix, Atomwise Team Up on Drug Discovery With MicroOrgans and AI	Sarah de Crescenzo	12/03/19	San Diego
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal	Frank Vinluan	12/03/19	San Francisco
Partner or Die: How to Succeed Even After the Digital Health Hype Quiets Down	Rob Coppedge	12/03/19	Seattle
Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer	Sarah de Crescenzo	12/03/19	National
Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule	Frank Vinluan	11/25/19	San Francisco
Ferring and Blackstone Team Up to Fund Gene Therapy Firm With $570M	Frank Vinluan	11/25/19	Boston
Five Questions With a16z’s Vijay Pande on AI and Making New Drugs	Sarah de Crescenzo	11/25/19	National
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More	Frank Vinluan	11/22/19	National
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow	Melissa Fassbender	11/20/19	San Francisco
Page 1 of 631	next page »

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Whitepaper
Accelerating Life Sciences Product Development & Commercialization
Best practices to drive digital adoption in life sciences
DocuSign